Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis
Background Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease. At present, three biological agents have been approved for treating SLE, including belimumab, anifrolumab, and telitacicept. However, a direct comparison of their efficacy and safety is lacking. Objective To a...
সংরক্ষণ করুন:
| প্রধান লেখক: | |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Chinês |
| প্রকাশিত: |
Chinese General Practice Publishing House Co., Ltd
2025-08-01
|
| মালা: | Zhongguo quanke yixue |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.chinagp.net/fileup/1007-9572/PDF/20230864.pdf |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|